Efficacy and Safety of SHR-2010 Injection in the Treatment of Primary IgA Nephropathy

NCT05847920 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
53
Enrollment
INDUSTRY
Sponsor class

Stopped Based on the adjustment of the R \& D strategy, the sponsor decides to terminate the research.

Conditions

Interventions

Sponsor

Guangdong Hengrui Pharmaceutical Co., Ltd